
BC Partners sells stake in Brenntag for €577.5m
BC Partners and co-investors have sold seven million shares in listed German chemicals company Brenntag, reducing their joint stake to 13.6%.
BC Partners, Bain Capital and Goldman Sachs owned shares in Brenntag through investments in Luxembourg-based holding company Brachem Acquisition SCA.
Brachem sold all of its seven million shares at €82.50 per share, reducing its stake to 13.6% of the entire share capital of Brenntag. Goldman Sachs acted as sole bookrunner in the accelerated bookbuilt offering. Following the divestment, Brachem has entered into a 180-day lock-up period.
Brenntag floated in March 2010 on the Frankfurt stock exchange, four years after BC Partners' initial investment in the chemicals company. The initial offering was priced at €50 per share and raised €747.5m. Goldman Sachs, Deutsche Bank, JP Morgan and Bank of America were joint bookrunners in the IPO.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater